Cargando…
A ‘synthetic-sickness’ screen for senescence re-engagement targets in mutant cancer backgrounds
Senescence is a universal barrier to immortalisation and tumorigenesis. As such, interest in the use of senescence-induction in a therapeutic context has been gaining momentum in the past few years; however, senescence and immortalisation remain underserved areas for drug discovery owing to a lack o...
Autores principales: | Cairney, Claire J., Godwin, Lauren S., Bilsland, Alan E., Burns, Sharon, Stevenson, Katrina H., McGarry, Lynn, Revie, John, Moore, Jon D., Wiggins, Ceri M., Collinson, Rebecca S., Mudd, Clare, Tsonou, Elpida, Sadaie, Mahito, Bennett, Dorothy C., Narita, Masashi, Torrance, Christopher J., Keith, W. Nicol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570495/ https://www.ncbi.nlm.nih.gov/pubmed/28806777 http://dx.doi.org/10.1371/journal.pgen.1006942 |
Ejemplares similares
-
Identification of a Selective G1-Phase Benzimidazolone Inhibitor by a Senescence-Targeted Virtual Screen Using Artificial Neural Networks()()
por: Bilsland, Alan E., et al.
Publicado: (2015) -
Cell-based screen for altered nuclear phenotypes reveals senescence progression in polyploid cells after Aurora kinase B inhibition
por: Sadaie, Mahito, et al.
Publicado: (2015) -
Cellular senescence and its effector programs
por: Salama, Rafik, et al.
Publicado: (2014) -
Mathematical Model of a Telomerase Transcriptional Regulatory Network Developed by Cell-Based Screening: Analysis of Inhibitor Effects and Telomerase Expression Mechanisms
por: Bilsland, Alan E., et al.
Publicado: (2014) -
Dynamic Telomerase Gene Suppression via Network Effects of GSK3 Inhibition
por: Bilsland, Alan E., et al.
Publicado: (2009)